MP-0260

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameMP-0260
Drug Alias NameMP-0260
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPlatelet-derived growth factor subunit B inhibitorsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor APlatelet-derived growth factor subunit B
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMolecular Partners AgAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesAllergan PlcMolecular Partners Ag
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A